Ticker

Page 1 • Showing up to 10

Date	Analyst	Firm	Target	Price @ Post	Source	Headline
November 14, 2025 9:13 pm	—	RBC Capital	$221.50	$217.71	TheFly	Cidara downgraded to Sector Perform from Outperform at RBC Capital
October 9, 2025 2:44 pm	Sara Nik	H.C. Wainwright	$150.00	$108.18	TheFly	Cidara Therapeutics price target raised to $150 from $110 at H.C. Wainwright
October 3, 2025 9:40 am	—	JMP Securities	$173.00	$98.50	TheFly	Cidara Therapeutics price target raised to $173 from $153 at Citizens JMP
September 26, 2025 10:06 am	—	H.C. Wainwright	$110.00	$86.60	TheFly	Cidara Therapeutics price target raised to $110 from $74 at H.C. Wainwright
September 24, 2025 5:09 pm	Roy Buchanan	JMP Securities	$153.00	$88.32	TheFly	Cidara Therapeutics price target raised to $153 from $66 at Citizens JMP
September 24, 2025 2:14 pm	Seamus Fernandez	Guggenheim	$167.00	$86.68	TheFly	Cidara Therapeutics price target raised to $167 from $70 at Guggenheim
September 24, 2025 1:23 pm	Brian Abrahams	RBC Capital	$137.00	$88.58	TheFly	Cidara Therapeutics price target raised to $137 from $115 at RBC Capital
July 9, 2025 12:22 pm	Seamus Fernandez	Guggenheim	$69.00	$50.96	StreetInsider	Cidara Therapeutics (CDTX) PT Raised to $69 at Guggenheim
June 24, 2025 11:39 am	—	Guggenheim	$68.00	$46.84	TheFly	Cidara Therapeutics price target raised to $68 from $50 at Guggenheim
May 16, 2025 12:33 pm	Seamus Fernandez	Guggenheim	$50.00	$25.50	TheFly	Cidara Therapeutics price target raised to $50 from $35 at Guggenheim

No recent news available for CDTX.

Insider Trading